TRANSMEDICS GROUP INC (TMDX) Stock News
NASDAQ:TMDX - Nasdaq - US89377M1099 - Common Stock - Currency: USD
TMDX Latest News, Press Relases and Analysis
Curious about the stocks that are showing activity after the closing bell on Thursday?
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Is TransMedics Group, Inc. (TMDX) the Unstoppable Growth Stock to Invest in Now?
We recently published a list of 11 Unstoppable Growth Stocks to Invest in Now. In this article, we are going to take a look at where TransMedics Group, Inc. (NASDAQ:TMDX) stands against other unstoppable growth stocks to invest in now. BlackRock highlighted that the trade conflict between the US and China continues to cause major economic […]
Roger Federer-backed On raises annual sales forecast as promotions, new launches fuel demand
(Reuters) -Roger Federer-backed On Holding raised its annual sales forecast on Tuesday and said it would have to undertake selective pricing to mitigate impacts from U.S. President Donald Trump's tariffs. The Trump administration has implemented a baseline 10% tariff on all trading partners globally with further tariffs on countries such as Vietnam and Indonesia on a 90-day pause. Vietnam faces a 46% tariff on exports to the U.S. if a reduction cannot be negotiated before the moratorium expires in July.
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
Why TransMedics Group (TMDX) Is Among the Best Performing Healthcare Stocks to Buy Now
We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where TransMedics Group, Inc. (NASDAQ:TMDX) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]
TransMedics Group, Inc. (TMDX): A Bull Case Theory
We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc. (TMDX)’s share was trading at $95.81 as of May 7th. TMDX’s trailing and forward P/E were 89.54 and 63.29 respectively according to Yahoo Finance. TransMedics […]
Mentions: VZ
Why TransMedics Stock Is Skyrocketing Today
TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.
Former Highflier TransMedics Catapults To Seven-Month High On Liver-Driven Beat
The company is an expert in getting donated livers, hearts and lungs to transplant recipients.
Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics
The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of 141.38% and 16.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: HYPR
TransMedics Reports First Quarter 2025 Financial Results
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
3 Mid-Cap Medical Stocks Outperforming the Market
Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
1 No-Brainer Vanguard ETF to Buy Right Now
Market turbulence has defined 2025's investment landscape as political brinkmanship over trade policy sent stocks on a wild ride. The initial shock of President Trump's aggressive tariff announcements triggered widespread selling, particularly in growth-oriented sectors with global supply chains and international revenue exposure. With many premier growth companies still trading well below their recent highs despite improving fundamentals, the current market environment favors those willing to look beyond short-term volatility.
2 Tariff-Resistant Growth Stocks to Buy With $120 Ahead of May
A tariff is a financial penalty imposed on imported products to protect or promote domestic manufacturing. In other words, its AI algorithm is more accurate at calculating the risk profile of borrowers.
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - TMDX
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ:...
INVESTOR DEADLINE TOMORROW: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TMDX
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly...
TMDX Deadline: TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between...
TMDX Investors Have the Opportunity to Lead the TransMedics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
TUESDAY DEADLINE: Berger Montague Advises TransMedics Group (NASDAQ: TMDX) Investors to Inquire About a Securities Fraud Class Action by April 15, 2025
/PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or...
TransMedics Group, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action...
